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Real-time characterization of risks of death
associated with the Middle East respiratory
syndrome (MERS) in the Republic of Korea, 2015
Kenji Mizumoto1, Akira Endo2, Gerardo Chowell3,4, Yuichiro Miyamatsu2,5, Masaya Saitoh2,5,6 and Hiroshi Nishiura2,5*
Abstract
Background: An outbreak of the Middle East respiratory syndrome (MERS), comprising 185 cases linked to
healthcare facilities, occurred in the Republic of Korea from May to July 2015. Owing to the nosocomial nature of
the outbreak, it is particularly important to gain a better understanding of the epidemiological determinants
characterizing the risk of MERS death in order to predict the heterogeneous risk of death in medical settings.
Methods: We have devised a novel statistical model that identifies the risk of MERS death during the outbreak in
real time. While accounting for the time delay from illness onset to death, risk factors for death were identified
using a linear predictor tied to a logit model. We employ this approach to (1) quantify the risks of death and (2)
characterize the temporal evolution of the case fatality ratio (CFR) as case ascertainment greatly improved
during the course of the outbreak.
Results: Senior persons aged 60 years or over were found to be 9.3 times (95 % confidence interval (CI), 5.3–16.9)
more likely to die compared to younger MERS cases. Patients under treatment were at a 7.8-fold (95 % CI, 4.0–16.7)
significantly higher risk of death compared to other MERS cases. The CFR among patients aged 60 years or older under
treatment was estimated at 48.2 % (95 % CI, 35.2–61.3) as of July 31, 2015, while the CFR among other cases
was estimated to lie below 15 %. From June 6, 2015, onwards, the CFR declined 0.3-fold (95 % CI, 0.1–1.1)
compared to the earlier epidemic period, which may perhaps reflect enhanced case ascertainment following
major contact tracing efforts.
Conclusions: The risk of MERS death was significantly associated with older age as well as treatment for
underlying diseases after explicitly adjusting for the delay between illness onset and death. Because MERS
outbreaks are greatly amplified in the healthcare setting, enhanced infection control practices in medical
facilities should strive to shield risk groups from MERS exposure.
Keywords: Case fatality ratio, Fatal outcome, Middle East respiratory syndrome, Risk factors, Statistical model,
South Korea
Background
When a novel infectious disease emerges, it is vital to
assess the potential global public health impact, i.e. the
potential of a pathogen to cause a devastating pandemic
[1]. The public health impact is mainly characterized by
the transmission potential and virulence, the latter of
which is usually measured by the case fatality ratio
(CFR), namely the proportion of deaths among cases [2].
Due to the importance of generating accurate estimates
of the CFR in real time as an outbreak progresses and
public health interventions are implemented, a number
of epidemiological methods have been proposed, includ-
ing those that account for the time delay from illness
onset to death [3–5] and those that correct for ascertain-
ment bias through the combination of several different
observations by employing a Bayesian evidence synthesis
method [6]. Other methods have developed a slightly
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different CFR concept, e.g. the so-called “infection fatal-
ity risk”, the ratio of excess mortality to the serologic-
ally determined infected fraction of the population [7].
The CFR is an important epidemiological quantity to
estimate in real time during outbreaks, and the recent
outbreak of the Middle East respiratory syndrome
(MERS) in the Republic of Korea in 2015 has not
been an exception [8]. Besides the MERS outbreak in
the Republic of Korea, earlier studies of MERS in the
Middle East have consistently indicated that the CFR
for MERS has been about 40 % [9] and could be as
low as 20 % for estimates that only include secondary
cases [10].
Despite the availability of useful methods to estimate
the CFR for MERS, it is crucial to identify risk factors
associated with MERS death, as the risk of death may
vary significantly with age, occupation, and underlying
comorbidities [11]. During the epidemic of severe acute
respiratory syndrome (SARS), a real-time analysis found
that confirmed or probable cases aged 60 years or older
were at greater risk of death than younger cases [12].
Moreover, infections with SARS-associated coronavirus
with comorbidities were found to be 1.7 times more
likely to die than those without comorbidities [13]. Due
to similarities in clinical characteristics between MERS
and SARS patients as both coronaviruses are closely
related [9], we can expect that the risk of MERS death
can also be similarly characterized by a set of underlying
epidemiological features of the cases. While the methods
for identifying the risk of death in real time during the
SARS epidemic have relied on survival analysis tech-
niques, including non-parametric Kaplan-Meier-like
methods [12, 14], there is a need to develop a simple yet
tractable method which is inspired on the adjustment of
censoring for CFR [4, 5] with particular application to
small outbreak sizes such as the MERS outbreak in
the Republic of Korea. Such a modelling framework
should adjust for case ascertainment, which is widely
recognized as a key issue that arises during emerging
disease epidemics, including the H1N1 pandemic in
2009 [2, 7, 8]. During the MERS outbreak in the Republic
of Korea, an extensive contact tracing effort was
made by public health authorities soon after the first
few cases were reported, with all cases being con-
firmed by laboratory testing irrespective of clinical
signs and symptoms. As in any outbreak, it is likely
that the ascertainment rate was substantially im-
proved as the outbreak progressed.
The present study aims to statistically identify risk
factors associated with MERS death in the Republic
of Korea using a simple but novel statistical model-
ling approach. We also use our approach to assess
the time dependent variation in the ascertainment of
cases.
Methods
Epidemiological data
The present study employs published secondary data of
the confirmed MERS cases arising from the outbreak in
the Republic of Korea [15–17]. As of July 31, 2015, a
total of 185 cases have been diagnosed (excluding one
case diagnosed and recovered in China) including 36
deceased cases. During the course of this outbreak, a
detailed line list of cases has been made publicly available
[15]. Data on individual cases include the (1) dates of
illness onset, (2) age-group, (3) gender, and (4) back-
ground health status either as outpatient or inpatient
of a specific healthcare facility. Since the dates of ill-
ness onset among those recently reported were not yet
available, we relied on the dates of confirmatory diag-
nosis as an alternative. We believe it is reasonable to
approximate the date of illness onset by the date of
confirmed diagnosis in this setting, because from the
midst of the outbreak, all suspected contacts have
been regularly monitored and have been subjected to
laboratory testing regardless of clinical signs and
symptoms. We limited ourselves to handle the above-
mentioned covariates (2) to (4) only, not each specific
individual comorbidity, because it is not clear if the
presence of all common underlying comorbidities were
routinely evaluated and consistently documented in
the case list; the identification of most closely associ-
ated specific comorbidities may be the subject of fu-
ture clinical studies.
Statistical model
Herein, we develop an estimation model composed of a
mixture of a survival model and logistic regression
model. Let S(τ) and p be the survival probability at time
τ since illness onset and the CFR, respectively. The rela-
tionship of the two is described as
p ¼ 1−S ∞ð Þ; ðiÞ
where S(τ) is given by
S τ; pð Þ ¼ 1−p
Zτ
0
f xð Þdx; ðiiÞ
where f(τ) is the conditional probability density function
of the time from illness onset to death given fatal out-
come [4, 18]. In the majority of the following analyses,
f(τ) was assumed as known and based on the data from
first 10 reported cases who eventually resulted in death
in South Korea, using the moment-based estimates of
the mean (13.2 days) and standard deviation (7.1 days).
Nevertheless, we also examined the heterogeneous risk
of death by jointly quantifying heterogeneous risk factors
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and parameters of f(τ), verifying that the estimates of
the risk of death in the joint estimation do not
greatly differ from those we obtained using the as-
sumed known f(τ).
Since we aim to identify risk factors (or explanatory
variables) of p, the notation p is set to be changeable by
individual i, i.e. pi. Such individual variation is modelled
using the logit model:
ln
pi
1−pi
 
¼ a0 þ
XN
k¼1
akxk;i; ðiiiÞ
where a0 is the intercept, ak the coefficient of variable k,
xk,i the k-th variable of individual i of the linear pre-
dictor, and N the total number of independent variables.
Let A and B represent the groups of cases who have sur-
vived and died by the most recent calendar time tm, the
likelihood function to parameterize the linear predictor
in (iii) is
L a;α;β; tmð Þ ¼
Y
i∈A
S tm−αi; pið Þ
Y
i∈B
pif βi−αi
  
; ðivÞ
where αi and βi represent the observed dates of illness
onset and death of an individual i, respectively, with
coefficient vector a = (a0, a1, ⋯, aN).
Estimation settings
In our analysis of the Korean MERS data in real time,
univariate analyses using the abovementioned logistic
regression were conducted to detect any variable as-
sociated with the risk of death. Explanatory dichot-
omous variables include age-group (below or above
60 years old), gender, and patients under treatment.
Patients under treatment include both outpatients
and inpatients, while non-patient cases represent all
other cases including healthcare workers, visitors, and
so on. The univariate test was achieved by estimating
the CFR at the most recent time tm for each sub-
group using the solution of pi obtained from (iii) and
calculating the difference of CFR between the esti-
mates. After identifying variables that were signifi-
cantly associated with MERS death from univariate
analyses, a multivariate version of the model (iii) was
run to adjust confounding factors and identify epi-
demiological factors that were significantly associated
with death.
Subsequently, we used exactly the same model as
(iii) to test if there was any time-dependent change
in the risk of death, perhaps due to increased ascer-
tainment involving diagnoses of a substantial number
of mild and asymptomatic cases. The time depend-
ence in the CFR was modelled by introducing a
parameter δ, a constant factor multiplied to the ori-
ginal logit model, i.e.
pi ¼
δ exp a0 þ
XN
k¼1
akxk;i
 !
1þ exp a0 þ
XN
k¼1
akxk;i
 ! ; ðvÞ
where δ was dealt with as
δ ¼ 1; for t < t0
ε; for t0≤ t
;

ðviÞ
where t0 represents the first day on which the ascertain-
ment rate increased while ε scales the extent of ascer-
tainment (where ε is expected to be less than 1); t0 was
objectively sought by comparing the Akaike Information
Criterion (AIC) among models with different t0.
When the joint estimation was conducted, we esti-
mated not only coefficients of the linear predictor in the
likelihood L but also parameters for f(τ), i.e. mean and
standard deviation of the gamma distribution. Parame-
ters were estimated using the maximum likelihood
method (i.e. by minimizing negative logarithm of (iv)).
The 95 % confidence intervals (CI) were derived from
the profile likelihood. Different models were compared
using the AIC.
Ethical considerations
The present study reanalyzed the publicly available
secondary data from the Korean Government and WHO
which collected the notification data with ethical ap-
proval and written consent from patients, and adhering
to the International Health Regulations. The secondary
data were de-identified by these organizations in ad-
vance of our access. As such, the datasets employed in
our study have been deemed exempted from the ethical
approval.
Availability of supporting data
The present study fully rests on published data, and
essential components of the data consisting of dates of
illness onset and death are downloadable from the
WHO website [15].
Results
Risk factors associated with MERS death
Table 1 shows the results of univariate analyses. Cases
among senior persons aged 60 years or over (P <0.01)
and patients under treatment (P <0.01) were significantly
associated with MERS death: senior persons appeared to
be 9.3-fold (95 % CI, 5.3–16.9) more likely to die com-
pared to younger cases and patients under treatment
were 7.8-fold (95 % CI, 4.0–16.7) more likely to be fatal
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than others. Gender was not found to be a significant
predictor of death (P = 0.57).
Table 2 summarizes the results derived from our
multivariate model analyses and includes the smallest
AIC value. Cases among senior persons and patients
under treatment were included in the final model.
Figure 1a indicates that the estimates of coefficients
remained stable over time, whereas Figure 1b illustrates
the estimated CFR by subgroups. As of July 31, 2015, the
CFR among patients aged 60 years or older under treat-
ment was estimated at 48.2 % (95 % CI, 35.2–61.3). The
CFRs in other subgroups were low and estimated as fol-
lows: 1.8 % in the lowest risk group (age <60 years with-
out any treatment), 13.6 % among those aged 60 years or
older without any treatment, and 11.1 % among those
aged younger than 60 years old under treatment.
Time dependent risk of MERS death
Using the time-dependent logit model, we quantified the
impact of improved case ascertainment. Importantly, the
date at which the risk of death most likely declined was
estimated to be June 6, 2015, as determined by the mini-
mum AIC value (401.9) with models (v) and (vi). ε was
estimated to be 0.3 (95 % CI, 0.1–1.1), indicating that
the case fatality ratio sharply declined by 70 % from
June 6, 2015, onwards. Although the estimated relative
change in the case fatality ratio was not significantly below
1, it should be noted that the AIC value of the model with
time-dependent decline in the CFR was smaller than the
alternative model without time-dependent decline in the
risk of death (AIC = 405.3).
Estimated time from illness onset to death
Jointly quantifying the time from illness onset to death,
the mean and standard deviation of the delay were esti-
mated at 14.6 (95 % CI, 11.5–19.5) days and 10.4 (95 %
CI, 7.6–16.2) days, respectively. The fixed mean and
standard deviation using first 10 deceased cases were
not significantly deviated from these estimates. Accord-
ingly, the estimated CFR by different types of individuals
were also not significantly different from those described
above (Fig. 2). As of July 31, 2015, the CFR among
patients aged 60 years or older under treatment was
estimated at 48.4 % (95 % CI, 35.4–61.6). The CFRs
in other subgroups were 1.8 % in the lowest risk group
(age <60 years without any treatment), 13.7 % among
those aged 60 years or older without any treatment, and
11.2 % among those aged younger than 60 years old
under treatment. The AIC value of the most up-to-date
joint model was 406.7, i.e. a value greater than that ob-
tained using the fixed mean and the standard deviation.
It should be noted that the joint estimation model
resulted in successful convergence only on and after
July 12, 2015, i.e. 10 days since illness onset of the
latest case on July 2, 2015.
Discussion
The present study has successfully devised a novel hy-
brid statistical model to characterize the heterogeneous
risk of death associated with MERS in real time in the
context of the most recent MERS outbreak in the
Republic of Korea from May to July 2015. Our method,
relying on the logit model, enabled us not only to iden-
tify epidemiological determinants of MERS death but
also to examine the time-dependent variation in CFR
due to an increased case ascertainment rate influenced
by extensive contact tracing efforts. We have shown that
cases among senior persons under treatment were at
particularly high risk of MERS death. In addition, we
have found that the CFR most likely declined since
June 6, 2015, by about 70 %.
We found marked similarities with SARS as the CFR
for MERS among patients aged 60 years or older under
treatment was estimated as high as 48.2 % (95 % CI,
35.2–61.3), while that for younger healthy individuals
was less than 15 % [12, 13]. Our CFR estimate for senior
persons was consistent with an overall CFR estimate of
40 % from prior studies [9]. Moreover, it can also explain
a decline in the CFR estimate among secondary cases in
the Middle East at 20 % [10, 19]: most secondary trans-
missions were among healthcare workers and visitors
without underlying comorbidities. Because MERS out-
breaks tend to be amplified in healthcare settings com-
prised by a significant fraction of vulnerable populations
(e.g. older populations with underlying comorbidities),
an important caveat derived from our analysis is that it
Table 1 Univariate association with the risk of death from
Middle East respiratory syndrome (MERS) (n = 185)
Variables Univariate odds ratio
(95 % confidence intervals)
P value
Age (≥60 years old) 9.3 (5.3–16.9) <0.01
Sex (female to male) 1.3 (0.8–2.1) 0.57
Patients under treatment 7.8 (4.0–16.7) <0.01
Univariate odds ratio was derived from the logit model with time-delay from
illness onset to death, while P values were derived from Fisher’s exact test
Table 2 Predicted risk factors of death from Middle East
respiratory syndrome (MERS) death using a real-time
multivariate model
Variables Coefficient a
(95 % confidence interval)
Adjusted odds ratio
(95 % confidence interval)
Intercept −3.9 (−4.7 to −3.1) 0.02 (0.01–0.04)
Age (≥60 years old) 2.0 (1.4–2.6) 7.6 (4.2–14.0)
Patients under
treatment
1.8 (1.1–2.6) 5.9 (2.9–12.8)
Negative log likelihood = 199.7; Dependent nominal variable = death
a Coefficient of the linear predictor
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is critical to enhance and maintain infection control
measures in healthcare settings not only to avoid sec-
ondary transmissions but also mitigate the mortality
burden. Countermeasures that minimize infections
among patients in healthcare settings, e.g. restricting the
number of visits to different hospitals per case, should
be taken into consideration.
It should be noted that the present study is not the
first to utilize statistical methods to estimate the hetero-
geneous risks of death in real time. Specifically, prior
studies on SARS have employed non-parametric survival
analysis during the course of the epidemic [3, 12] and a
method for estimating relative case fatality was proposed
elsewhere [20]. However, compared to earlier models,
the proposed model was shown to be advantageous in
two aspects. First, our approach allowed us to pinpoint a
sharp decline in the CFR over time by using only a sin-
gle multiplicative parameter. Indeed, the reason behind a
decline in CFR by 70 % since June 6, 2015, is consistent
with an increased case ascertainment due to extensive
contact tracing efforts during the outbreak which has
inherently increased the diagnosis of very mild cases. If
we aim to estimate the risk of death among all infected
individuals [7], the corresponding estimate is likely lower
than what we presented here. Second, as we employed
the logistic type model, our method is able to handle
very small sample sizes for each subgroup of cases. By
using the logit model, our approach was able to success-
fully identify risk factors from very small samples
(i.e. 185 cases and 36 deaths) for the MERS outbreak
in the Republic of Korea.
In addition to characterizing the heterogeneous and
time dependent risks of MERS death, we have also
estimated the time from illness onset to death jointly
with other parameters, confirming that the risk estimates
of each group were consistent with those derived from a
model with fixed mean and standard deviation of the
time from illness onset to death. The goodness-of-fit
assessed by AIC indicated that joint estimation did not
contribute to improve model fit to the data in a com-
parative sense, but as practiced in the present study, the
joint estimation procedure can help verify the CFR esti-
mates of each risk group using the known distribution of
time from illness onset to death.
Two limitations have to be noted. First, our exercise
involved only a limited number of covariates as potential
determinants of MERS death. The publicly available case
list sometimes included descriptions regarding specific
Fig. 1 Estimated case fatality ratios of Middle East respiratory syndrome (MERS) by subgroups in the Republic of Korea, 2015. a Estimated value of
regression coefficient as a function of calendar time. The horizontal straight grey line represents zero value. b Estimated case fatality ratio (CFR) by
subgroup as a function of calendar time. The horizontal dashed grey lines correspond to the published value of the CFR (i.e., 20 % and 40 %)
[9, 10]. In both panels, the horizontal axis represents the date at which the estimation was implemented. Upper and lower 95 % confidence
intervals (CI) for each parameter derived from the profile likelihood are indicated by the whiskers
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comorbidities, but we were not able to ensure that all
common comorbidities were systematically and consist-
ently documented in the list. Second, we had to reach a
compromise with some data gaps. In particular, when-
ever the date of illness onset was unavailable, the date of
confirmatory diagnosis was used as a proxy. However,
considering that Korean public health investigators have
successfully conducted major contact tracing efforts and
tested all suspected cases, the difference between these
two time variables appeared to have been small (e.g.
among cases who developed illness in the latter half of
June 2015, the median time elapsed from illness onset to
diagnosis was only 2 days). The same issue applies to the
interpretation of the date of death. In contrast to the
substantial differences between the actual and reported
date of death for cases of the Ebola virus disease out-
breaks in West Africa, the close monitoring of MERS
cases in South Korea enabled us to analyze the actual
date of death in real time.
Our study was aimed to identify key determinants of
MERS death using a simple framework in real time, and
future studies could aim to carry out a more thorough
analysis of the final dataset that could include more
information. While there are certainly further opportun-
ities to improve our methods and conduct further
similar studies in other settings, our statistical approach
has allowed us to successfully identify patients aged
60 years or older under treatment at particularly high-
risk of MERS death in real time. Our model also
helped us capture the impact of increased ascertain-
ment in Korea as reflected in our estimate of the CFR
from the midst of the outbreak. Considering that
MERS tends to be amplified in healthcare settings
[21], the need to enhance and maintain strict infection
control measures at hospitals to avoid secondary trans-
missions, particularly among high risk groups, cannot
be overemphasized.
Conclusion
The risk of MERS death was significantly associated with
older age as well as treatment for underlying diseases
after explicitly adjusting for the delay between illness
onset and death. Because MERS outbreaks are greatly
amplified in the healthcare setting, enhanced infection
control practices in medical facilities should strive to
shield risk groups from MERS exposure. The proposed
model can be used for other outbreaks of emerging in-
fectious diseases including those involving small number
of cases and time-dependent variation in the ascertain-
ment rate.
Fig. 2 Joint estimation of the time from illness onset to death and type-specific case fatality ratio of Middle East respiratory syndrome (MERS) in
the Republic of Korea, 2015. a Mean and standard deviation of the time from illness onset to death. b Estimated case fatality ratio (CFR) by
subgroup as a function of calendar time. In both panels, the horizontal axis represents the date at which the estimation was implemented. Upper
and lower 95 % confidence intervals (CI) for each parameter derived from the profile likelihood are indicated by the whiskers
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